Cargando…

Prävalenz von SARS-CoV-2 bei Kindern in einer Kohorte von 2192 Patienten

BACKGROUND: As of 18 June 2020 a total of 187,764 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were reported in Germany and of these 6.9% were under the age of 19 years. There were initial indications that children are often asymptomatic and show a milder clinical course....

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer, M., Rübsteck, E., Lehmann, C., Klein, F., Gruell, H., Hünseler, C., Weber, L. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676857/
https://www.ncbi.nlm.nih.gov/pubmed/33235395
http://dx.doi.org/10.1007/s00112-020-01067-8
_version_ 1783611860675723264
author Meyer, M.
Rübsteck, E.
Lehmann, C.
Klein, F.
Gruell, H.
Hünseler, C.
Weber, L. T.
author_facet Meyer, M.
Rübsteck, E.
Lehmann, C.
Klein, F.
Gruell, H.
Hünseler, C.
Weber, L. T.
author_sort Meyer, M.
collection PubMed
description BACKGROUND: As of 18 June 2020 a total of 187,764 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were reported in Germany and of these 6.9% were under the age of 19 years. There were initial indications that children are often asymptomatic and show a milder clinical course. OBJECTIVE: The aim of this study was to gain information on the prevalence of SARS-CoV‑2 infections in a pediatric cohort. MATERIAL AND METHODS: Between 13 March and 18 June 2020 all children from whom a smear for SARS-CoV‑2 was taken either to rule out an infection or as a suspected case were included. Data were collected on standardized patient record sheets. The analysis of data was anonymized and retrospective. RESULTS: During the given period 2192 children were investigated and 37 patients tested positive (1.7%) for SARS-CoV‑2. Of these 36/37 were suspected cases and 28/37 were symptomatic. The leading symptoms were dry cough, runny nose and fever and three children had to be hospitalized. None showed a difficult course of the disease. Among those tested 505 were patients at risk due to an underlying chronic disease, 3 of whom (0.6%) were tested positive with an asymptomatic or mild course. CONCLUSION: We can confirm the first data showing that children and adolescents often have an asymptomatic or mild clinical course of infection or disease. We found no evidence of a high grey area of SARS-CoV‑2 infections in this regional pediatric cohort.
format Online
Article
Text
id pubmed-7676857
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-76768572020-11-20 Prävalenz von SARS-CoV-2 bei Kindern in einer Kohorte von 2192 Patienten Meyer, M. Rübsteck, E. Lehmann, C. Klein, F. Gruell, H. Hünseler, C. Weber, L. T. Monatsschr Kinderheilkd Originalien BACKGROUND: As of 18 June 2020 a total of 187,764 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were reported in Germany and of these 6.9% were under the age of 19 years. There were initial indications that children are often asymptomatic and show a milder clinical course. OBJECTIVE: The aim of this study was to gain information on the prevalence of SARS-CoV‑2 infections in a pediatric cohort. MATERIAL AND METHODS: Between 13 March and 18 June 2020 all children from whom a smear for SARS-CoV‑2 was taken either to rule out an infection or as a suspected case were included. Data were collected on standardized patient record sheets. The analysis of data was anonymized and retrospective. RESULTS: During the given period 2192 children were investigated and 37 patients tested positive (1.7%) for SARS-CoV‑2. Of these 36/37 were suspected cases and 28/37 were symptomatic. The leading symptoms were dry cough, runny nose and fever and three children had to be hospitalized. None showed a difficult course of the disease. Among those tested 505 were patients at risk due to an underlying chronic disease, 3 of whom (0.6%) were tested positive with an asymptomatic or mild course. CONCLUSION: We can confirm the first data showing that children and adolescents often have an asymptomatic or mild clinical course of infection or disease. We found no evidence of a high grey area of SARS-CoV‑2 infections in this regional pediatric cohort. Springer Medizin 2020-11-19 2021 /pmc/articles/PMC7676857/ /pubmed/33235395 http://dx.doi.org/10.1007/s00112-020-01067-8 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Originalien
Meyer, M.
Rübsteck, E.
Lehmann, C.
Klein, F.
Gruell, H.
Hünseler, C.
Weber, L. T.
Prävalenz von SARS-CoV-2 bei Kindern in einer Kohorte von 2192 Patienten
title Prävalenz von SARS-CoV-2 bei Kindern in einer Kohorte von 2192 Patienten
title_full Prävalenz von SARS-CoV-2 bei Kindern in einer Kohorte von 2192 Patienten
title_fullStr Prävalenz von SARS-CoV-2 bei Kindern in einer Kohorte von 2192 Patienten
title_full_unstemmed Prävalenz von SARS-CoV-2 bei Kindern in einer Kohorte von 2192 Patienten
title_short Prävalenz von SARS-CoV-2 bei Kindern in einer Kohorte von 2192 Patienten
title_sort prävalenz von sars-cov-2 bei kindern in einer kohorte von 2192 patienten
topic Originalien
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676857/
https://www.ncbi.nlm.nih.gov/pubmed/33235395
http://dx.doi.org/10.1007/s00112-020-01067-8
work_keys_str_mv AT meyerm pravalenzvonsarscov2beikindernineinerkohortevon2192patienten
AT rubstecke pravalenzvonsarscov2beikindernineinerkohortevon2192patienten
AT lehmannc pravalenzvonsarscov2beikindernineinerkohortevon2192patienten
AT kleinf pravalenzvonsarscov2beikindernineinerkohortevon2192patienten
AT gruellh pravalenzvonsarscov2beikindernineinerkohortevon2192patienten
AT hunselerc pravalenzvonsarscov2beikindernineinerkohortevon2192patienten
AT weberlt pravalenzvonsarscov2beikindernineinerkohortevon2192patienten